AMYLOID CARDIOMYOPATHY
Clinical trials for AMYLOID CARDIOMYOPATHY explained in plain language.
Never miss a new study
Get alerted when new AMYLOID CARDIOMYOPATHY trials appear
Sign up with your email to follow new studies for AMYLOID CARDIOMYOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a diabetes drug ease heart failure in rare amyloid disease?
Symptom relief CompletedThis study tested the drug dapagliflozin (a diabetes medicine) in 50 adults with heart failure due to amyloid cardiomyopathy, a rare condition where abnormal proteins stiffen the heart. Researchers measured changes in quality of life, walking distance, and heart stress markers ov…
Matched conditions: AMYLOID CARDIOMYOPATHY
Phase: NA • Sponsor: National Medical Research Center for Cardiology, Ministry of Health of Russian Federation • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Could your lifetime workout routine protect your heart?
Knowledge-focused CompletedThis study looked at whether being physically active over a lifetime is linked to developing a rare heart disease called wild-type transthyretin amyloid cardiomyopathy. Researchers compared the exercise histories of 180 people over age 60, including those with the disease, those …
Matched conditions: AMYLOID CARDIOMYOPATHY
Sponsor: Medical University of Graz • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:28 UTC
-
Protein clues could spot rare disease years early
Knowledge-focused CompletedThis study followed 37 people with a genetic risk for hereditary ATTR amyloidosis over five years. Researchers measured levels of misfolded proteins in the blood to see if they could detect the earliest signs of the disease. The goal is to develop a way to catch the condition bef…
Matched conditions: AMYLOID CARDIOMYOPATHY
Sponsor: The Cleveland Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC